How can induced pluripotent stem cells help researchers test potential new drugs?

Created from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles.

Induced pluripotent stem cells (iPS cells) are transformative tools in drug development because they allow researchers to create human models of disease in the laboratory. By reprogramming a patient’s own adult cells—such as skin cells—into a pluripotent state, scientists can generate cells that carry the specific genetic mutations associated with that patient's condition.12

These patient-specific cells can be used in several ways to test new drugs:

  • Disease Modeling: Researchers can differentiate iPS cells into the specific cell types affected by a disease, such as neurons for Alzheimer disease or amyotrophic lateral sclerosis, to observe disease mechanisms in a controlled environment.2
  • Drug Screening: These models serve as platforms to screen potential new drugs for safety and effectiveness, allowing scientists to observe how specific tissues respond to treatment before clinical trials.12
  • Personalized Medicine: Because the cells contain the patient's unique genetic makeup, they enable the investigation of personalized treatments, helping researchers understand how different individuals might respond to various therapies.1

By providing a human-derived alternative to animal models, iPS cells help bridge the gap between laboratory research and clinical application.12